| Financial Year |
March 31 2023 |
| Monetary Funds |
30,013,778.81 |
| Held-for-trading Financial Assets |
29,769,928.08 |
| Notes Receivable |
72,776,326.82 |
| Accounts Receivable |
826,224,743.65 |
| Advances to Suppliers |
10,416,936.26 |
| Other Receivables |
2,296,585.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
216,822,548.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,167,642.60 |
| Total Current Assets |
1,198,586,362.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,565,455.39 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,299,691.70 |
| R&D expenses |
-- |
| Goodwill |
454,564,147.76 |
| Long-Term Deferred and Prepaid Expenses |
339,875.86 |
| Deferred Income Tax Assets |
1,024,401.66 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
478,347,759.73 |
| Total Assets |
1,676,934,122.56 |
| Short-Term Loans |
214,643,825.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
243,366,489.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,550,687.80 |
| Taxes Payable |
17,427,946.69 |
| Interest Payable |
-- |
| Dividend Payable |
27,300,000.00 |
| Other payables |
838,474,664.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,675,281.22 |
| Other Current Liabilities |
211,400.28 |
| Sub-Total of Current Liabilities |
1,332,308,228.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
318,423.84 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,416,568.50 |
| Total Liabilities |
1,336,724,797.27 |
| Paid-In Capital(Or Share Stock) |
290,090,435.60 |
| Capital Surplus |
382,326,715.72 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-606,830,094.32 |
| Minority Stockholder's Interest |
266,930,025.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
73,279,299.83 |
| Owner's Equity（Stockholder's Equity） |
340,209,325.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,676,934,122.56 |
